IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRLAB Therapeutics AB
Gross Profit Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Gross Profit
-kr122.7m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Gross Profit
kr1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Gross Profit
kr1.5B
CAGR 3-Years
53%
CAGR 5-Years
98%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Gross Profit
kr1.4B
CAGR 3-Years
80%
CAGR 5-Years
75%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Gross Profit
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Gross Profit
-kr126.9m
CAGR 3-Years
-306%
CAGR 5-Years
-291%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Gross Profit?
Gross Profit
-122.7m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Gross Profit amounts to -122.7m SEK.

What is IRLAB Therapeutics AB's Gross Profit growth rate?
Gross Profit CAGR 3Y
-23%

Over the last year, the Gross Profit growth was -89%. The average annual Gross Profit growth rates for IRLAB Therapeutics AB have been -23% over the past three years .

Back to Top